Viking Therapeutics
VKTX
VKTX
390 hedge funds and large institutions have $2.02B invested in Viking Therapeutics in 2025 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 148 increasing their positions, 107 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
390
Holders Change
+21
Holders Change %
+5.69%
% of All Funds
5.23%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
84
Increased
148
Reduced
107
Closed
59
Calls
$231M
Puts
$97.6M
Net Calls
+$134M
Net Calls Change
+$7.52M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$33.4M |
| 2 |
Two Sigma Advisers
New York
|
+$28.9M |
| 3 |
Millennium Management
New York
|
+$18.3M |
| 4 |
Citigroup
New York
|
+$16.5M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$15.8M |
Top Sellers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$39.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.8M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$26.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.6M |
| 5 |
BlackRock
New York
|
-$14.3M |
